FDA Comes Down Hard on Eli Lilly’s Dog Medication

5:12 am

Eli Lilly recently came out with a new drug that was supposed to help alleviate separation anxiety in dogs, and the company has been selling the drug to veterinarians in several markets. However, according to a story that appeared today in the Indianapolis Star, the FDA has rebuked the benefits of this drug.

The FDA issued a warning letter on June 26, stating in part that Lilly was issuing "misleading" and "incomplete" promotional information on the drug, called Reconcile, and asked the company to immediately stop, according to the article linked hereto.

The crux of the issue is that Eli Lilly was promoting positive statistics regarding the results of dogs using the drug, but did not disclose that the dogs in question were also receiving behavior modification therapy to aid in this condition.

Leave a Reply

Your email address will not be published. Required fields are marked *